BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 114570
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114570
Table 3 Comparisons of the postoperative clinical course and laboratory data of the patients with and without early complications
Variables
Patients with early complications (n = 29)
Patients without early complications (n = 76)
P value
Length of hospital stay (days) (mean ± SD)13.17 ± 6.58.84 ± 2.8< 0.001
Follow-up period (months) (mean ± SD)43.52 ± 2647.55 ± 250.472
Disease-free survival (months) (mean ± SD)40.31 ± 2643.32 ± 240.581
Hemoglobin (g/dL)
Postoperative day 110.37 ± 111.15 ± 1.20.003
Neutrophil/Lymphocyte ratio (mean ± SD)
Postoperative day 1 (mean ± SD)13.75 ± 5.59.50 ± 3.7< 0.001
Postoperative day 3 (mean ± SD)10.06 ± 4.47.45 ± 3.60.003
Eosinophil/Lymphocyte ratio
Postoperative day 1 (mean ± SD)0.04 ± 0.20.04 ± 0.10.993
Postoperative day 3 (mean ± SD)0.17 ± 0.20.16 ± 0.20.923
Lymphocyte/monocyte ratio
Postoperative day 1 (mean ± SD)2.02 ± 1.71.97 ± 1.20.869
Postoperative day 3 (mean ± SD)2.40 ± 0.92.38 ± 0.80.927
Disease course0.290
Remission19 (65.5)57 (75)
Progression3 (10.3)10 (13.2)
Mortality7 (24.1)9 (11.8)


Write to the Help Desk